Ondansetron Clinical Pharmacokinetics (Q40431009)

From Wikidata

Jump to navigation Jump to search

scientific article published on August 1, 1995

edit

Language	Label	Description	Also known as
English	Ondansetron Clinical Pharmacokinetics	scientific article published on August 1, 1995

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

7586904

retrieved

20 September 2017

review article

1 reference

stated in

Europe PubMed Central

title

Ondansetron clinical pharmacokinetics (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

7586904

retrieved

20 September 2017

Ondansetron Clinical Pharmacokinetics (English)

1 reference

stated in

Crossref

DOI

10.2165/00003088-199529020-00004

reference URL

https://api.crossref.org/works/10.2165/00003088-199529020-00004

retrieved

26 May 2024

main subject

pharmacokinetics

1 reference

based on heuristic

inferred from title

author name string

F. Roila

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

7586904

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7586904

retrieved

26 May 2024

A. Del Favero

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

7586904

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7586904

retrieved

26 May 2024

language of work or name

English

1 reference

stated in

National Center for Biotechnology Information

PubMed publication ID

7586904

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7586904

retrieved

26 May 2024

publication date

1 August 1995

1 reference

stated in

Europe PubMed Central

PubMed publication ID

7586904

retrieved

20 September 2017

published in

Clinical Pharmacokinetics

1 reference

stated in

Europe PubMed Central

PubMed publication ID

7586904

retrieved

20 September 2017

volume

29

1 reference

stated in

Europe PubMed Central

PubMed publication ID

7586904

retrieved

20 September 2017

issue

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

7586904

retrieved

20 September 2017

page(s)

95-109

1 reference

stated in

Europe PubMed Central

PubMed publication ID

7586904

retrieved

20 September 2017

cites work

High-performance liquid chromatographic separation of ondansetron enantiomers in serum using a cellulose-derivatized stationary phase and solid-phase extraction

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7586904

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase I/II study of the 5-HT3 antagonist GR38032F in the anti-emetic prophylaxis of patients receiving high-dose cisplatin chemotherapy

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7586904

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relationships between ondansetron systemic exposure and antiemetic efficacy and safety in cancer patients receiving cisplatin

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7586904

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The metabolism of ondansetron

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7586904

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A sensitive radioimmunoassay, combined with solid-phase extraction, for the sub-nanogram per ml determination of ondansetron in human plasma.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7586904

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of the pharmacokinetics of an ondansetron solution (8 mg) when administered intravenously, orally, to the colon, and to the rectum

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7586904

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of the anti-emetic efficacy of different doses of ondansetron, given as either a continuous infusion or a single intravenous dose, in acute cisplatin-induced emesis. A multicentre, double-blind, randomised, parallel group study. Ondansetr

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7586904

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ondansetron metabolism and pharmacokinetics

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7586904

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Drug metabolism in liver disease

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7586904

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ondansetron by subcutaneous infusion

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7586904

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ondansetron absorption in adults: effect of dosage form, food, and antacids

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7586904

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Correlation of anti-emetic efficacy and plasma levels of ondansetron

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7586904

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The determination in plasma and pharmacokinetics of ondansetron

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7586904

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Subcutaneous ondansetron

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7586904

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The pharmacokinetics of ondansetron after intravenous injection in healthy volunteers phenotyped as poor or extensive metabolisers of debrisoquine

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7586904

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The polymorphic cytochrome P-4502D6 is involved in the metabolism of both 5-hydroxytryptamine antagonists, tropisetron and ondansetron

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7586904

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Age and gender effects on ondansetron pharmacokinetics: evaluation of healthy aged volunteers

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7586904

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oral ondansetron pharmacokinetics: the effect of chemotherapy

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7586904

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The pharmacokinetics of intravenous ondansetron in patients with hepatic impairment

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7586904

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Concentration of ondansetron in cerebrospinal fluid following oral dosing in volunteers

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7586904

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Stratified, randomized, double-blind comparison of intravenous ondansetron administered as a multiple-dose regimen versus two single-dose regimens in the prevention of cisplatin-induced nausea and vomiting

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7586904

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The chemistry of ondansetron.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7586904

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Determination of Ondansetron in Plasma and Its Pharmacokinetics in the Young and Elderly

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7586904

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mechanism of intestinal absorption of ranitidine and ondansetron: transport across Caco-2 cell monolayers

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7586904

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antiemetic efficacy and pharmacokinetic analyses of the serotonin antagonist ondansetron (GR 38032F) during multiple-day chemotherapy with cisplatin prior to autologous bone marrow transplantation

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7586904

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The clinical pharmacology of ondansetron

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7586904

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reducing chemotherapy-induced nausea and vomiting. Current perspectives and future possibilities

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/7586904

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.2165/00003088-199529020-00004

1 reference

stated in

Europe PubMed Central

PubMed publication ID

7586904

retrieved

20 September 2017

Dimensions Publication ID

1019612855

0 references

PubMed publication ID

7586904

1 reference

stated in

Europe PubMed Central

PubMed publication ID

7586904

retrieved

20 September 2017

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40431009&oldid=2203682996"